|
|
|
| home > white papers > Maximize the ROI of Your Post-Approval Research - Bioclinica |
|
|
 WHITE PAPERS |
|
|
Bioclinica
|
|
Maximize the ROI of Your Post-Approval Research
|
|
Expenditures in post-approval (Phase IV) research are going up across
the pharmaceutical, biotech and medical device industries. Given the
resources you’ve committed to post-approval research, you may be
wondering if you’re getting the greatest possible return on your
investment.
Discover how to harness the power of post-approval
research to increase data collection, reduce resource burn, save money,
and maximize your ROI!
|
|
|
|
|
|
|
 |
News and Press Releases |
 |
HATRIC-based identification of receptors for orphan ligands (small molecules)
HATRIC-LRC (Ligand Receptor Capture) enables now the identification of
small molecule targets on the surface of living cells! Even primary
cells!
More info >> |
|
 |
White Papers |
 |
|
Migration safe pharmaceutical labels improve patient safety
UPM Raflatac
Labels play an invaluable role on pharmaceutical packages. Pharmaceutical companies should only use labels that meet low-leachability and extraction requirements. Labels that are not migration safe, e.g. create leachable chemical compounds, may fail testing and result in significant launch delays or costly recalls. This white paper presents how pharmaceutical companies can ensure that the final label constructions achieve their business, regulatory and patient safety goals.
More info >> |
|
 |
Industry Events |
 |
ACHEMA 2018
11-15 June 2018, Messe Frankfurt GmbH
ACHEMA is the world forum for the process industries, but also an
integral part of the trade show calendar of companies specializing in pharma
packaging. Every three years 3,800 exhibitors and 170,000 visitors gather in
Frankfurt/Main, Germany for the trade show that features everything you need to
furnish a chemical or pharma production plant.
More info >> |
|
|
|
